CONTACT
Contact Us
From research to practical applications,
let’s explore new ways to work together.
Biozipcode, Inc. works with universities, research institutions, pharmaceutical and biotech companies, medical institutions, other businesses, and investors, drawing on diabetes stem cell research and Biozipcode™ cell-targeting technology.
We welcome inquiries about collaborative research, technology evaluation, licensing, co-development, clinical development, and business partnerships at different stages.
If you do not yet have a specific project in mind, please contact us to explore how our research and technologies might fit your work.
Discussions about collaborative research or business partnerships may eventually require sharing unpublished research data, technical information before patent filing, candidate sequences, or trade secrets. However, submitting the contact form does not establish a nondisclosure agreement.
Please provide only nonconfidential information sufficient to describe the potential collaboration in your first inquiry. If confidential information needs to be shared, we can sign a nondisclosure agreement (NDA) where appropriate and arrange a suitable exchange.
Contact Us
TEL:
03-6821-7318
MAIL:
info@biozipcode.com
Address
2F-C, Shibuya Dogenzaka Tokyu Building, 1-10-8 Dogenzaka, Shibuya-ku, Tokyo 150-0043, Japan
SNS
Contact Form
CONTACT PURPOSE
Choose the topic that fits your inquiry.
RESEARCH COLLABORATION
Research Collaboration
We welcome inquiries about collaborative research with universities, research institutions, medical institutions, and pharmaceutical and biotech companies.
Potential areas include diabetes stem cells, biomarkers, Biozipcode™, cell targeting, DDS, cancer, tissue regeneration, and bioinformatics, combining our research base with new technologies or disease areas.
LICENSING
Technology Licensing
We welcome inquiries from companies and research institutions interested in licensing or adopting our research findings, intellectual property, Biozipcode™ technologies, and diabetes-related technologies.
After reviewing the technology, intended use, territory, and development stage, we can provide further details under an NDA where appropriate.
CO-DEVELOPMENT
Co-Development
We welcome inquiries about co-developing research findings into defined products and services.
These could include medicines, diagnostics, research reagents, cell-capture technologies, DDS, medical devices, and regenerative materials, combining partners’ products and technologies with Biozipcode™ as appropriate.
MEDICAL INQUIRIES
Medical & Treatment Inquiries
This contact channel cannot provide advice about an individual patient’s diagnosis, treatment plan, prescription, or medication changes.
We also cannot determine whether diabetes stem cell research, Biozipcode™, 5-ALA, investigational therapies, biomarkers, or other subjects described on this site are appropriate for an individual patient.
Please consult your treating physician, pharmacist, or another qualified healthcare professional about your symptoms or treatment.
Please do not send medical records, test results, images, genetic information, or other sensitive health information through the general contact form.
If we recruit participants for a research study or clinical trial, the institution conducting that specific study, eligibility criteria, and contact details will be announced separately.
CONTACT US
Could we explore new possibilities
in research, technology, and business together?
We aim to bring research findings beyond papers and laboratories and develop them into new diagnostic and therapeutic technologies.
That takes partners with expertise in research, pharmaceuticals, diagnostics, manufacturing, clinical practice, informatics, business development, and investment.
Please contact us to explore new possibilities with Biozipcode™ and diabetes stem cell research.
